Senate panel to examine blood substitute study

02/24/2006 | Wall Street Journal, The

Sen. Charles E. Grassley, R-Iowa, chairman of the Senate Finance Committee, is questioning Northfield Laboratories' and the FDA's actions regarding a 720-patient trauma study of a blood substitute. Grassley is looking into whether patients were aware of potential side effects and the full results of a previous study on PolyHeme.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID